The global Clinical Trial Acceleration Platforms (Ctaps) Market is experiencing a paradigm shift, transitioning from traditional site-centric models to highly efficient, patient-focused digital ecosystems. This rapid digitalization is fueling massive market growth. Valued at USD 1.48 billion in 2024, the market is projected to skyrocket, reaching USD 4.86 billion by the end of 2032, r... https://www.databridgemarketresearch.com/